Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-08

Clinical Trial Update: Minocycline and Aspirin in the Treatment of Bipolar Depression [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating minocycline and aspirin for bipolar depression has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • Minocycline (minocycline)

Snippet

Sponsor: Laureate Institute for Brain Research, Inc. | Conditions: Bipolar Disorder Depression | Phase 3 | Status: COMPLETED | Results posted: 2017-11-08